Controlled and Targeted Drug Delivery by a UV‐responsive Liposome for Overcoming Chemo‐resistance in Non‐Hodgkin Lymphoma

By  

CHEMICAL BIOLOGY & DRUG DESIGN (ELECTRONIC), Vol. 86, Iss. 4, 2015-10 ,pp. : 783-794

John Wiley & Sons Inc

Access to resources Recommend Favorite

Novel Targeted Agents in Hodgkin and Non-Hodgkin Lymphoma Therapy

By Grover Natalie S.   Park Steven I.  

Pharmaceuticals, Vol. 8, Iss. 3, 2015-09 ,pp. : 607-636

MDPI

Access to resources Recommend Favorite

Sam68 regulates cell proliferation and cell adhesion‐mediated drug resistance (CAM‐DR) via the AKT pathway in non‐Hodgkin's lymphoma

By  

CELL PROLIFERATION (ELECTRONIC), Vol. 48, Iss. 6, 2015-12 ,pp. : 682-690

John Wiley & Sons Inc

Access to resources Recommend Favorite

Surfaceome of classical Hodgkin and non‐Hodgkin lymphoma

By  

PROTEOMICS - CLINICAL APPLICATIONS, Vol. 9, Iss. 7-8, 2015-08 ,pp. : 661-670

John Wiley & Sons Inc

Access to resources Recommend Favorite

Lack of TERT Promoter Mutations in Human B-Cell Non-Hodgkin Lymphoma

By Lam Gary   Xian Rena R.   Li Yingying   Burns Kathleen H.   Beemon Karen L.  

Genes, Vol. 7, Iss. 11, 2016-10 ,pp. : 93-93

MDPI

Access to resources Recommend Favorite